COMP <GO>
PROF vs JNJ // GROSS PROFIT MARGIN
Profound Medical Corp. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: PROF 3
— JNJ 7
▲ GROSS PROFIT MARGIN LEADER: PROF
LAST: $5.86 (+1.38%) • MKT CAP: $214.1M
gross-margins
70.80%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PROF VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PROF | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 70.80% | 67.90% | +2.90 | PROF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 25.50% | -60.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.93% | 2.97% | -20.90 | JNJ | /fcf-yield <GO> |
| Operating Margin | -60.00% | 34.70% | -94.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 28.50% | -88.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 65.30% | 6.00% | +59.30 | PROF | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.97 | 5.59 | +0.38 | PROF | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.7 | 62.1 | -3.37 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $214.1M | $662.49B | -$662.28B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PROF REV | JNJ REV | PROF GROSS % | JNJ GROSS % | PROF FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.1M | $94.19B | 70.8% | 67.9% | -$38.4M | $19.70B |
| FY 2024 | $9.7M | $88.82B | 72.2% | 69.1% | -$23.5M | $19.84B |
| FY 2023 | $5.9M | $85.16B | — | — | -$22.6M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PROF // BETA —
JNJ // BETA 1.08